Comparative Pharmacology
Head-to-head clinical analysis: ISOPTO CETAMIDE versus OPHTHOCHLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOPTO CETAMIDE versus OPHTHOCHLOR.
ISOPTO CETAMIDE vs OPHTHOCHLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Sulfacetamide inhibits bacterial dihydropteroate synthase, disrupting folic acid synthesis and thereby inhibiting bacterial growth.
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.
1-2 drops into conjunctival sac every 2-3 hours initially, then taper as infection resolves. Ophthalmic suspension (10% or 30%).
Chloramphenicol 0.5% ophthalmic solution: Instill 1-2 drops into the affected eye(s) every 3-4 hours for 7-10 days. For severe infections, every 2 hours initially. Ointment: Apply a small amount (about 0.5 cm) into the conjunctival sac every 3-4 hours.
None Documented
None Documented
Terminal elimination half-life of sodium sulfacetamide is 7-12 hours in normal renal function; prolonged in renal impairment.
5-6 hours in normal renal function; prolonged up to 24-48 hours in severe renal impairment
Primarily renal (sodium sulfacetamide excreted unchanged in urine, ~85% within 24 hours). Minor biliary/fecal elimination.
Renal: 70-80% unchanged; biliary/fecal: 20-30%
Category C
Category C
Ophthalmic Antibiotic
Ophthalmic Antibiotic